SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing intense selling pressure despite beating analyst expectations for both earnings and revenue, with investors highlighting significant concerns over declining margins, tariff headwinds, and a loss of market relevance compared to newer competitors. The community is sharply divided, with some viewing the drop to multi-year lows as a generational buying opportunity, while others are calling for aggressive short positions, citing a lack of growth, political fatigue, and a failed turnaround strategy.

Tema ETF Trust - Tema Space Innovators ETF

Investors are actively debating the potential of the newly launched space-focused ETF, with many drawing comparisons to other high-volatility funds due to its significant exposure to companies like SpaceX. Sentiment is mixed as participants weigh the excitement over the sector's growth potential against questions regarding the fund's underlying structure and liquidity.

Applied Digital Corporation

Applied Digital is experiencing heightened volatility and intense community discussion, driven by fears of geopolitical instability and its impact on the AI infrastructure sector. Investors are actively debating whether the current sell-off creates a prime buying opportunity ahead of upcoming earnings and potential hyperscaler contract announcements, or if the stock is facing a deeper structural decline.

Ganymede

Investors are actively accumulating Ganymede, focusing on its stable structure and disciplined price action while debating the potential for a community-driven surge.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the company's transition into a commercial-stage biotech following the recent FDA approval of Yartemlea and a high-value partnership with Novo Nordisk. The community remains focused on the early commercial launch trajectory, upcoming milestone payments, and the stock's significant potential for rerating as institutional interest grows.

Maul Coin

Maul Coin is gaining momentum as a community-driven project with an active developer, fueled by social media campaigns to drive organic growth and holder participation. Investors are actively discussing the coin's potential to reach major market cap milestones and are focused on building a loyal, long-term community while awaiting additional platform listings and charts.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is surging today following a strategic partnership and a 2 billion dollar equity investment in Marvell, which investors view as a major move to solidify the AI infrastructure stack. The community is actively debating whether this signals a sustained recovery for semiconductor stocks or if the rally is merely a short-term reaction to institutional capital injections amidst broader geopolitical uncertainty.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is rallying following the announcement of a multi-year, $99 million sole-source government contract, a development community members view as a significant validation of its space-based intelligence tech stack. Investors are actively debating the company's long-term strategic positioning within the defense sector, with many pointing to the backlog growth and potential for future contract scaling as key drivers for long-term conviction.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending as investors debate the impact of the upcoming April earnings report and potential U.S. cannabis policy updates, with community sentiment divided between bullish anticipation of a regulatory breakthrough and bearish concerns regarding dilution and management's strategic focus on the declining beverage market. Discussions are heavily focused on the company's ability to capitalize on U.S. rescheduling alongside broader sector volatility, with many participants closely monitoring the stock's price action as it navigates significant technical pressure.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors react to the upcoming earnings release and intense speculation surrounding a potential acquisition, with the community actively debating whether a deal with a major industry player is imminent. While bulls are focused on the strategic value of the company's spectrum assets and recent partnership news, discussion remains heavily split between those anticipating a high-premium buyout and skeptics concerned about long-term valuation and past performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?

Insmed (INSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026

Keros lines up 2026 catalysts with rinvatercept at the core, including a Q2 DMD phase II start and ALS regulatory plans as execution shifts into focus.

KROS: Is the Discount Book Value a Value Trap?

Keros posts a 2025 revenue surge from Takeda licensing, but no product sales and volatile drivers leave investors weighing a discounted valuation against execution risk.

KROS Stock: What to Know About Rinvatercept in DMD

Keros advances rinvatercept in DMD with orphan status, fresh phase I data, and a planned Q2 2026 phase II start driving its near-term execution story.

Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Update

Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling...

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Average Recommendation of "Hold" from Analysts

Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) has been assigned a consensus recommendation of "Hold" from the ten analysts that are presently covering the company, Marketbeat reports. One...

Q1 EPS Estimate for Keros Therapeutics Decreased by Analyst

Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share estimates for Keros Therapeutics in a report released on Thursday, March 5th. HC...

Keros Therapeutics (NASDAQ:KROS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Keros Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?

KROS advances rinvatercept for Duchenne muscular dystrophy, with a phase II trial planned for 2026 after gaining FDA orphan drug designation.

What is HC Wainwright's Estimate for KROS FY2030 Earnings?

Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings per share estimates for Keros Therapeutics in a research report issued to clients and...

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Keros Therapeutics Inc

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

KROS
Keros Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KROS News

KROSKeros Therapeutics Inc